EFSCE
PTLA

Enterprise Financial Services Corp (EFSC)’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Enterprise Financial Services Corp (EFSC)’s Portfolio PTLA Stock Details PTLA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-75
Closed -$2K – 1097
2018
Q3 		$2K Buy
+75
New +$2.45K ﹤0.01% 964

Other funds holding PTLA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Enterprise Financial Services Corp (EFSC)'s PTLA Position: Q4 2018 in Review

Enterprise Financial Services Corp (EFSC) sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q4 2018, closing a stake of 75 shares — an estimated $2K sold.

Enterprise Financial Services Corp (EFSC) first reported a position in PTLA in Q3 2018 and held it in 1 quarter. The position peaked at $2K in Q3 2018. 181 funds tracked by Wall St. Rank hold PTLA as of Q4 2018.

  • Enterprise Financial Services Corp (EFSC) reported no remaining Portola Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
  • Enterprise Financial Services Corp (EFSC) sold 75 Portola Pharmaceuticals, Inc. shares in Q4 2018, an estimated $2K.
  • Enterprise Financial Services Corp (EFSC) first reported a position in Portola Pharmaceuticals, Inc. in Q3 2018 and held it in 1 quarter.
  • Enterprise Financial Services Corp (EFSC)'s Portola Pharmaceuticals, Inc. position peaked at $2K in Q3 2018.
  • 181 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q4 2018.

Based on Enterprise Financial Services Corp (EFSC)'s 13F filing for Q4 2018, filed 25 Jan 2019.